Literature DB >> 24740681

NLRPs, microbiota, and gut homeostasis: unravelling the connection.

Lia Paola Zambetti1, Alessandra Mortellaro.   

Abstract

Within the NOD-like receptor (NLR) family, there are several NLRP (NLR family, pyrin domain-containing) proteins that are involved in the formation of inflammasomes. These multi-protein complexes are a key part of the network of cellular events required for secretion of the pro-inflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome is the best-characterized member of the family and has recently been implicated in gut homeostasis and determining the severity of inflammation in inflammatory bowel disease (IBD) and inflammation-associated colorectal cancer. This led to the discovery that NLRP6 and NLRP12 also contribute to the maintenance of intestinal homeostasis and modulation of the gut microbiota, which in turn influences the intestine and distant organs. In this review, we bring together the latest data on the potential roles of NLRP family members in gut health and disease and identify the most pressing questions that remain to be answered to further our understanding of human diseases including IBD, inflammation-associated cancers, and metabolic syndromes linked with obesity.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  NLRP; inflammasome; intestinal inflammation; intestinal tumourigenesis; microbiota

Mesh:

Substances:

Year:  2014        PMID: 24740681     DOI: 10.1002/path.4357

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

Review 1.  Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.

Authors:  Maayan Levy; Christoph A Thaiss; Meirav N Katz; Jotham Suez; Eran Elinav
Journal:  Semin Immunopathol       Date:  2014-10-15       Impact factor: 9.623

2.  Intrinsic flexibility of NLRP pyrin domains is a key factor in their conformational dynamics, fold stability, and dimerization.

Authors:  Roland G Huber; Clarissa Eibl; Julian E Fuchs
Journal:  Protein Sci       Date:  2014-12-26       Impact factor: 6.725

3.  The innate immune receptor NLRP12 maintains intestinal homeostasis by regulating microbiome diversity.

Authors:  Jenny Moi-Fong Lau; Yvonne Dombrowski
Journal:  Cell Mol Immunol       Date:  2017-07-24       Impact factor: 11.530

4.  NLR members in inflammation-associated carcinogenesis.

Authors:  Ha Zhu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2017-04-03       Impact factor: 11.530

5.  Gain-of-function SNPs in NLRP3 and IL1B genes confer protection against obesity and T2D: undiscovered role of inflammasome genetics in metabolic homeostasis?

Authors:  Juliana de Moraes Rodrigues; Dhemerson Souza de Lima; Vinicius N C Leal; Adriana A Bosco; Valeria Sandrim; Alessandra Pontillo
Journal:  Endocrine       Date:  2017-06-20       Impact factor: 3.633

6.  NLRP3 inflammasome activation triggers gasdermin D-independent inflammation.

Authors:  Chun Wang; Tong Yang; Jianqiu Xiao; Canxin Xu; Yael Alippe; Kai Sun; Thirumala-Devi Kanneganti; Joseph B Monahan; Yousef Abu-Amer; Judy Lieberman; Gabriel Mbalaviele
Journal:  Sci Immunol       Date:  2021-10-22

Review 7.  Innate immunity in diabetes and diabetic nephropathy.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

8.  Altered expression of inflammasomes in Hirschsprung's disease.

Authors:  Hiroki Nakamura; Anne Marie O'Donnell; Naoum Fares Marayati; Christian Tomuschat; David Coyle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2018-11-01       Impact factor: 1.827

Review 9.  The health advantage of a vegan diet: exploring the gut microbiota connection.

Authors:  Marian Glick-Bauer; Ming-Chin Yeh
Journal:  Nutrients       Date:  2014-10-31       Impact factor: 5.717

Review 10.  Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome.

Authors:  Luiz H A Cavalcante-Silva; José G F M Galvão; Juliane Santos de França da Silva; José M de Sales-Neto; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2015-11-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.